Please login to the form below

Not currently logged in
Email:
Password:

Astellas announces winner of 2009 awards

Astellas Pharma Europe, has presented the International Foundation for Dermatology with one of its 'Changing Tomorrow' charity awards, 2009

Astellas Pharma Europe, has presented the International Foundation for Dermatology with one of its 'Changing Tomorrow' charity awards, 2009.

The awards fund organisations that help citizens, of all communities, realise their full potential and enhance their quality of life: both today and in the future.

Mr Masao Yoshida, President and CEO of Astellas Pharma Europe, said: "The International Foundation for Dermatology supports many important projects in the developing world. We are pleased, via the Astellas 'Changing Tomorrow' charity awards, to help this worthwhile Foundation make a difference to improve dermatology training in countries of need."

The International Foundation of Dermatology (IFD), one of four recipients of the Astellas 'Changing Tomorrow' charity awards, was created in 1987 as an arm of the International Committee of Dermatology of the International League of Dermatological Societies (ILDS).

The IFD is a non-profit organisation whose principal mission is to improve dermatological care in underserved areas of the developing world. It is responsible for training primary care leads and dermatologists in subsaharan Africa from the Regional Dermatology Training Centre in Tanzania and has developed programmes in other countries such as Mali and Mexico.

Professor Roderick Hay, chairman of The International Foundation of Dermatology, said: "The IFD is delighted to have received this award and the associated funding. This contribution will specifically help us to support patients suffering from skin diseases in developing countries and at the same time provide dermatology training to local primary care workers."

The awards complement Astellas' existing ongoing corporate social responsibility (CSR) programmes which embody a global and European commitment to supporting medical research and education and uphold the company's strong ethical principles.

Among the main CSR-initiatives is the Astellas Pharma Europe Foundation, a registered charity with a long-term goal of providing support for programmes and activities that contribute to the advancement of an increasingly healthy society.

Recent beneficiaries of the Foundation include Save the Children Liberia, which has been able to vaccinate 35,000 children against measles and a total of 45,000 children against other childhood diseases.

Astellas Pharma Europe employs approximately 3,400 people in Central and Eastern Europe, as well as the Middle East and Africa. Dedicated to improving people's lives around the world through the introduction of innovative and reliable pharmaceutical products, it has key strengths in the therapy areas of transplantation, urology, dermatology and anti-infectives.

3rd November 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics